PATENT CLAIM ANALYSIS

Application Number: 16077063
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["250", "282000"]

Abstract:
Disclosed is a method of diagnosing cancer in a subject, comprising determining a level of one or more volatile organic compounds for cancer in a urine sample obtained from the subject, wherein the identity and/or the level of the biomarker is determined by a mass spectrometry method, such as gas chromatography-mass spectrometry or tandem mass spectrometry. Specific biomarkers identified using the method and the use of the method to identify subjects as requiring treatment for cancers are also disclosed.

Claim (Index 13):
A method according to  claim 1 , wherein the cancer is selected from bladder, renal, lung, prostate, pancreatic, breast or colorectal cancer.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 96.0
- Lexical Diversity: 1.55556
- Patent Class: 250.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14903706', '11992000', '13817285', '11373833', '15039806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7217937182949211
- 35 USC 102 Novelty (BERT): 0.4978272566990721
- Combined Prediction Score: 0.6993970721353362
- Mean Citation Score: 213.706364
- Max Citation Score: 219.61003
- Similarity Product: 143.21468325785875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test